Raphaël de Coninck will be speaking at a seminar on recent antitrust developments in the pharmaceutical sector. Details are available here.
SEP licensing in the United States: Understanding the impact on US business
US Business Survey On behalf of ACT | The App Association, consultants with Charles River Associates undertook a survey of US businesses that use technical...